Pretreatment with interleukin 35-engineered mesenchymal stem cells protected against lipopolysaccharide-induced acute lung injury via pulmonary inflammation suppression

Acute lung injury (ALI)-triggered pulmonary injury has been associated with high mortality, despite advances in drug treatment and supportive therapy. Remarkable progress has been made in attenuating the inflammatory injury associated with ALI using mesenchymal stem cells (MSCs)-based cell and gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoning, Zhang, Zhiqiang, Ju, Mingyan, Li, Jiaci, Jing, Yaqing, Zhao, Yuxia, Gu, Chao, Dong, Ming, Li, Guang, Liu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095386/
https://www.ncbi.nlm.nih.gov/pubmed/32170527
http://dx.doi.org/10.1007/s10787-020-00696-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095386/
https://www.ncbi.nlm.nih.gov/pubmed/32170527
http://dx.doi.org/10.1007/s10787-020-00696-5

Ejemplares similares